BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37461372)

  • 1. A case of ovarian carcinosarcoma with a germline pathogenic variant of BRCA2 involving a perforated appendix with an abscess.
    Saito A; Yamashita E; Sakurai U; Hirasawa A; Tanioka M; Tamura K; Umezawa S
    J Obstet Gynaecol Res; 2023 Oct; 49(10):2553-2557. PubMed ID: 37461372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinosarcoma of the ovary in a patient with a germline BRCA2 mutation: evidence for monoclonal origin.
    Sonoda Y; Saigo PE; Federici MG; Boyd J
    Gynecol Oncol; 2000 Feb; 76(2):226-9. PubMed ID: 10637076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Peritoneal Carcinosarcoma in a Breast Cancer Patient Harboring a Germline
    Mendes Gomes LB; Lazari Sandoval R; Bragança Xavier C; Strava Correa T; Koga Matuda RM; Silva de Souza Z; Cernaglia Aureliano de Lima LG; Petaccia de Macedo M; Marino Carvalho F; Assad Suzuki D
    Case Rep Oncol; 2024; 17(1):1-9. PubMed ID: 38179550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare case of ovarian carcinosarcoma with squamous cell carcinoma.
    Daimon A; Fujiwara S; Tanaka Y; Tanaka T; Ohmichi M
    J Ovarian Res; 2019 Apr; 12(1):32. PubMed ID: 30947745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ovarian Carcinosarcoma Associated with Cowden Syndrome-A Case Report].
    Higuchi D; Matsuura T; Takamine E; Hosokawa M; Kobori K; Ikeda S; Harada S; Honma K; Tajima A; Yoshida M; Otsuka I
    Gan To Kagaku Ryoho; 2022 Jul; 49(7):783-787. PubMed ID: 35851351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients.
    Zhang Y; Wu H; Yu Z; Li L; Zhang J; Liang X; Huang Q
    BMC Cancer; 2022 Aug; 22(1):842. PubMed ID: 35918668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carcinosarcoma of the ovary treated with paclitaxel and carboplatin chemotherapy - a report of 4 cases].
    Otsuka I; Takaya H; Takagi K; Tanaka A; Kaseki H; Izuta C; Sato M; Matsuura T; Suzuki Y
    Gan To Kagaku Ryoho; 2013 Sep; 40(9):1249-53. PubMed ID: 24047791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraft.
    Glaser G; Weroha SJ; Becker MA; Hou X; Enderica-Gonzalez S; Harrington SC; Haluska P
    PLoS One; 2015; 10(5):e0126867. PubMed ID: 25962155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Peritoneal Cancer After Risk-Reducing Bilateral Salpingo-Oophorectomy for Women With Germline
    Phillips KA; Friedlander ML
    J Clin Oncol; 2022 Jun; 40(17):1850-1852. PubMed ID: 35333598
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case and literature review of ovarian carcinosarcoma with long-term survival after repeated recurrences].
    Asano M; Hasegawa K; Tsukada K; Tada S; Mizoguchi Y; Imaeda Y; Ikeda M; Kawamura K; Fujii T
    Gan To Kagaku Ryoho; 2014 Aug; 41(8):1031-6. PubMed ID: 25132040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol.
    Steenbeek MP; van Bommel MHD; intHout J; Peterson CB; Simons M; Roes KCB; Kets M; Norquist BM; Swisher EM; Hermens RPMG; ; Lu KH; de Hullu JA
    Int J Gynecol Cancer; 2023 Jun; 33(6):982-987. PubMed ID: 37045546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of first-line chemotherapy regimens for ovarian carcinosarcoma: a single institution case series and review of the literature.
    Brackmann M; Stasenko M; Uppal S; Erba J; Reynolds RK; McLean K
    BMC Cancer; 2018 Feb; 18(1):172. PubMed ID: 29426293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil.
    Cotrim DP; Ribeiro ARG; Paixão D; de Queiroz Soares DC; Jbili R; Pandolfi NC; Cezana C; de Cássia Mauro C; Mantoan H; Bovolim G; de Brot L; Torrezan GT; Carraro DM; Baiocchi G; da Cruz Formiga MN; da Costa AABA
    BMC Cancer; 2019 Jan; 19(1):4. PubMed ID: 30606148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
    Alhuqail AJ; Alzahrani A; Almubarak H; Al-Qadheeb S; Alghofaili L; Almoghrabi N; Alhussaini H; Park BH; Colak D; Karakas B
    Breast Cancer Res Treat; 2018 Apr; 168(3):695-702. PubMed ID: 29297111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral ovarian teratoma complicated with carcinosarcoma in a 68 year old woman: a case report.
    Shanmughapriya S; SenthilKumar G; Balakrishnan K; Vasanthi N; Vinodhini K; Natarajaseenivasan K
    BMC Cancer; 2011 Jun; 11():218. PubMed ID: 21639901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic
    Alenezi WM; Fierheller CT; Revil T; Serruya C; Mes-Masson AM; Foulkes WD; Provencher D; El Haffaf Z; Ragoussis J; Tonin PN
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of germline and somatic BRCA1/2 genetic variants through parallel testing of patients with high-grade serous ovarian cancer: a national retrospective audit.
    Frugtniet B; Morgan S; Murray A; Palmer-Smith S; White R; Jones R; Hanna L; Fuller C; Hudson E; Mullard A; Quinton AE
    BJOG; 2022 Feb; 129(3):433-442. PubMed ID: 34657373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline BRCA2 Pathogenic Variant in Primary Breast Cancer of a Down Syndrome Individual.
    Shinohara T; Asoda T; Nakano Y; Yamada H; Fujimori Y
    Am J Case Rep; 2023 Dec; 24():e942208. PubMed ID: 38157332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline Pathogenic Variants in
    Lieberman S; Goldvaser H; Levy-Lahad E
    J Clin Oncol; 2022 May; 40(14):1590-1594. PubMed ID: 35286153
    [No Abstract]   [Full Text] [Related]  

  • 20. A spectrum of BRCA1 and BRCA2 germline deleterious variants in ovarian cancer in Russia.
    Kechin A; Boyarskikh U; Barinov A; Tanas A; Kazakova S; Zhevlova A; Khrapov E; Subbotin S; Mishukova O; Kekeeva T; Demidova I; Filipenko M
    Breast Cancer Res Treat; 2023 Jan; 197(2):387-395. PubMed ID: 36367610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.